MERLIN: Two-Year Results of Brolucizumab in Participants With Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid.
Ophthalmology
; 2024 Aug 23.
Article
in En
| MEDLINE
| ID: mdl-39182627
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Ophthalmology
Year:
2024
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos